STAT+: What to expect from UniQure’s upcoming Huntington’s gene therapy readout
Before the end of September, UniQure is expected to report four-year results from the closely tracked clinical trial of its gene therapy for Huntington’s disease.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.